CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,154 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01454297
NCT01454297N/ACompleted
CompareCT.gov

A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship Between Patient Outcomes, Treatment Regimens and Molecular Profiles

Multiple Myeloma Research Foundation·observational·Posted Oct 19, 2011·Updated Jan 3, 2024

In Brief

An observational study for Multiple Myeloma. Completed, enrolled 1,154 participants across 73 sites in 3 countries.

Detailed Summary

The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of the disease.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Myeloma
CountriesCanada, Spain, United States
CollaboratorsTranslational Genomics Research Institute, Corewell Health West, Van Andel Research Institute

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 19, 2011
Enrollment StartJul 1, 2011
Primary CompletionNov 30, 2023
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 12.4 yearsPosted 14.7 years ago